BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32007960)

  • 1. Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2.
    Glascock J; Sampson J; Connolly AM; Darras BT; Day JW; Finkel R; Howell RR; Klinger KW; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2020; 7(2):97-100. PubMed ID: 32007960
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
    Glascock J; Sampson J; Haidet-Phillips A; Connolly A; Darras B; Day J; Finkel R; Howell RR; Klinger K; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2018; 5(2):145-158. PubMed ID: 29614695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.
    Strauss KA; Farrar MA; Muntoni F; Saito K; Mendell JR; Servais L; McMillan HJ; Finkel RS; Swoboda KJ; Kwon JM; Zaidman CM; Chiriboga CA; Iannaccone ST; Krueger JM; Parsons JA; Shieh PB; Kavanagh S; Tauscher-Wisniewski S; McGill BE; Macek TA
    Nat Med; 2022 Jul; 28(7):1381-1389. PubMed ID: 35715566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial.
    Strauss KA; Farrar MA; Muntoni F; Saito K; Mendell JR; Servais L; McMillan HJ; Finkel RS; Swoboda KJ; Kwon JM; Zaidman CM; Chiriboga CA; Iannaccone ST; Krueger JM; Parsons JA; Shieh PB; Kavanagh S; Wigderson M; Tauscher-Wisniewski S; McGill BE; Macek TA
    Nat Med; 2022 Jul; 28(7):1390-1397. PubMed ID: 35715567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep disordered breathing in infants identified through newborn screening with spinal muscular atrophy.
    Chiang J; Xiao L; Nigro E; St-Laurent A; Weinstock L; Law E; Janevski J; Kuyntjes S; Cithiravel N; Tran T; Wolter NE; Gonorazky H; Amin R;
    Sleep Med; 2023 Nov; 111():161-169. PubMed ID: 37778092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal muscular atrophy: a time for screening.
    Prior TW
    Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infantile spinal muscular atrophy (SMA).
    Chabrol B; Desguerre I
    Arch Pediatr; 2020 Dec; 27(7S):7S1-7S2. PubMed ID: 33357590
    [No Abstract]   [Full Text] [Related]  

  • 10. Augmenting the SMN Protein to Treat Infantile Spinal Muscular Atrophy.
    Kim JK; Monani UR
    Neuron; 2018 Mar; 97(5):1001-1003. PubMed ID: 29518354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn Screening for SMA - Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?
    Blaschek A; Kölbel H; Schwartz O; Köhler C; Gläser D; Eggermann K; Hannibal I; Schara-Schmidt U; Müller-Felber W; Vill K
    J Neuromuscul Dis; 2022; 9(5):597-605. PubMed ID: 35848034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spinal muscular atrophy : Time for newborn screening?].
    Vill K; Blaschek A; Schara U; Kölbel H; Hohenfellner K; Harms E; Olgemöller B; Walter MC; Müller-Felber W
    Nervenarzt; 2017 Dec; 88(12):1358-1366. PubMed ID: 29101527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counselling.
    Rudnik-Schöneborn S; Berg C; Zerres K; Betzler C; Grimm T; Eggermann T; Eggermann K; Wirth R; Wirth B; Heller R
    Clin Genet; 2009 Aug; 76(2):168-78. PubMed ID: 19780763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gene copy ratios of SMN1/SMN2 in Japanese carriers with type I spinal muscular atrophy.
    Diep Tran T; Kroepfl T; Saito M; Nagura M; Ichiseki H; Kubota M; Toda T; Sakakihara Y
    Brain Dev; 2001 Aug; 23(5):321-6. PubMed ID: 11504604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal muscular atrophy diagnostics.
    Prior TW
    J Child Neurol; 2007 Aug; 22(8):952-6. PubMed ID: 17761649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nusinersen: antisense oligonucleotide to increase SMN protein production in spinal muscular atrophy.
    Paton DM
    Drugs Today (Barc); 2017 Jun; 53(6):327-337. PubMed ID: 28799578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between SMN2 methylation and disease severity in Chinese children with spinal muscular atrophy.
    Cao YY; Qu YJ; He SX; Li Y; Bai JL; Jin YW; Wang H; Song F
    J Zhejiang Univ Sci B; 2016 Jan; 17(1):76-82. PubMed ID: 26739529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.
    Kannan A; Jiang X; He L; Ahmad S; Gangwani L
    Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of neuropathophysiology in spinal muscular atrophy type I.
    Harding BN; Kariya S; Monani UR; Chung WK; Benton M; Yum SW; Tennekoon G; Finkel RS
    J Neuropathol Exp Neurol; 2015 Jan; 74(1):15-24. PubMed ID: 25470343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: A cohort study.
    Aragon-Gawinska K; Seferian AM; Daron A; Gargaun E; Vuillerot C; Cances C; Ropars J; Chouchane M; Cuppen I; Hughes I; Illingworth M; Marini-Bettolo C; Rambaud J; Taytard J; Annoussamy M; Scoto M; Gidaro T; Servais L
    Neurology; 2018 Oct; 91(14):e1312-e1318. PubMed ID: 30158155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.